U.S., March 29 -- ClinicalTrials.gov registry received information related to the study (NCT06900283) titled 'Quality of Life As a Predictor of OS and PFS in Patients with Lung Cancer' on March 21.
Brief Summary: By 2020, lung cancer continues leading the first cause of cancer mortality and the second most common type of cancer in the world. There are limitations to early detection and then more than 60% of patients are diagnosed in advanced stages where there are no longer curative options; that situation is associated with high mortality and poor survival. It is known that some clinical and biochemical parameters of the disease have been recognized as prognostic factors; however, it has been described that a reduction in the overall glob...